BG105549A - Използване на n-заместени азабициклоалканови производни за лечение на заболявания на централната нервна система - Google Patents

Използване на n-заместени азабициклоалканови производни за лечение на заболявания на централната нервна система

Info

Publication number
BG105549A
BG105549A BG105549A BG10554901A BG105549A BG 105549 A BG105549 A BG 105549A BG 105549 A BG105549 A BG 105549A BG 10554901 A BG10554901 A BG 10554901A BG 105549 A BG105549 A BG 105549A
Authority
BG
Bulgaria
Prior art keywords
nervous system
central nervous
treating diseases
substituted
azabicycloalkane derivatives
Prior art date
Application number
BG105549A
Other languages
English (en)
Inventor
Gerd Steiner
Rainer Munschauer
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschedorf
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG105549A publication Critical patent/BG105549A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

Изобретението се отнася до използване на N-заместени 3-азабициклоалканови производни с формула, в която В, R1, R2 и n имат значенията, посочени в описанието, за лечение на пристрастяване и на други заболявания на централната нервна система.
BG105549A 1998-11-24 2001-05-30 Използване на n-заместени азабициклоалканови производни за лечение на заболявания на централната нервна система BG105549A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (1)

Publication Number Publication Date
BG105549A true BG105549A (bg) 2001-12-29

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105549A BG105549A (bg) 1998-11-24 2001-05-30 Използване на n-заместени азабициклоалканови производни за лечение на заболявания на централната нервна система

Country Status (21)

Country Link
EP (1) EP1133293A1 (bg)
JP (1) JP2002530333A (bg)
KR (1) KR20010080535A (bg)
CN (1) CN1328455A (bg)
AR (1) AR021502A1 (bg)
AU (1) AU1775300A (bg)
BG (1) BG105549A (bg)
BR (1) BR9915589A (bg)
CA (1) CA2352526A1 (bg)
CZ (1) CZ20011796A3 (bg)
DE (1) DE19854147A1 (bg)
HK (1) HK1040933A1 (bg)
HR (1) HRP20010472A2 (bg)
HU (1) HUP0104416A3 (bg)
IL (1) IL143181A0 (bg)
NO (1) NO20012538L (bg)
PL (1) PL348758A1 (bg)
SK (1) SK7112001A3 (bg)
TR (1) TR200101476T2 (bg)
WO (1) WO2000030639A1 (bg)
ZA (1) ZA200103976B (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2000030639A1 (de) 2000-06-02
AU1775300A (en) 2000-06-13
CZ20011796A3 (cs) 2002-05-15
ZA200103976B (en) 2002-05-16
DE19854147A1 (de) 2000-05-25
BR9915589A (pt) 2001-08-07
HK1040933A1 (zh) 2002-06-28
JP2002530333A (ja) 2002-09-17
PL348758A1 (en) 2002-06-03
HUP0104416A2 (hu) 2002-04-29
SK7112001A3 (en) 2001-12-03
EP1133293A1 (de) 2001-09-19
IL143181A0 (en) 2002-04-21
HUP0104416A3 (en) 2002-11-28
NO20012538D0 (no) 2001-05-23
KR20010080535A (ko) 2001-08-22
TR200101476T2 (tr) 2001-10-22
AR021502A1 (es) 2002-07-24
HRP20010472A2 (en) 2003-04-30
CA2352526A1 (en) 2000-06-02
CN1328455A (zh) 2001-12-26
NO20012538L (no) 2001-07-04

Similar Documents

Publication Publication Date Title
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
YU11501A (sh) Derivati 4,4,-biarilpiperidina sa aktivnošću na receptor opijata
BG106586A (bg) Пиразолопиримидини като терапевтични средства
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
MY121047A (en) Bicyclo [2.2.1] heptanes and related compounds
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
BG102872A (bg) 6-фенилпиридил-2-аминови производни
BG102999A (bg) Нови 2,3 дизаместени-4(3н)-хиназолинони
BG105270A (bg) Тетрахидропиридоетери
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
BG104356A (bg) Съединение на базата на азабензимидазол, метод занеговото получаване и използването му за модулиране на серин/ треонинова протеин киназна функция
YU25399A (sh) 6-fenilpiridil-2-amino derivati korisni kao nos inhibitori
IL129592A0 (en) 5-HT1f agonists
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BG103947A (bg) Производни на 9-оксимеритромицин
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
IL114754A0 (en) Benzimidazole derivatives
BG105710A (bg) 5-нт1 антагонисти за антидепресантно лечение
BG103687A (bg) Атропизомери на 3-хетероарил-4(3н)-хиназолинони за лечение на нервнодегенеративни процеси и състояния, свързани с травми на цнс
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
IL135634A0 (en) 5-htif agonists
BG105549A (bg) Използване на n-заместени азабициклоалканови производни за лечение на заболявания на централната нервна система